Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Prescription Drugs

  • U.S. Constitution vs. FDA: Off-Label Discussions No Longer Faux Pas?

    The First Amendment to the U.S. Constitution states in totality, “Congress shall make no law respecting an...
  • Indivior, Drug to Fight Opioid Addiction, Approved by U.S. FDA

    Indivior’s experimental drug to help fight America’s growing opioid addiction crisis was approved by the U.S. Food...
  • Prescription-Drug Monitoring Saves Lives, Could Save More

    State programs that monitor narcotic prescriptions help prevent 10 opioid-overdose deaths a day in the U.S., yet...

U.S. Constitution vs. FDA: Off-Label Discussions No Longer Faux Pas?

June 20, 2019 - Kenneth Alan Totz, DO, JD, FACEP - 0 Comment

The First Amendment to the U.S. Constitution states in totality, “Congress shall make no law respecting an…

Read More

Indivior, Drug to Fight Opioid Addiction, Approved by U.S. FDA

December 5, 2017 - Reuters Staff - 0 Comment

Indivior’s experimental drug to help fight America’s growing opioid addiction crisis was approved by the U.S. Food…

Read More

Prescription-Drug Monitoring Saves Lives, Could Save More

July 28, 2016 - Ronnie Cohen (Reuters Health) - 1 Comment

State programs that monitor narcotic prescriptions help prevent 10 opioid-overdose deaths a day in the U.S., yet…

Read More

FDA Seeks Suspension of 4,402 Illegal Prescription Drug Websites

July 12, 2016 - Reuters Staff - 0 Comment

The U.S. Food and Drug Administration said it, along with international authorities, has formally sought to suspend…

Read More

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603